Thermax Limited enters Q1 FY27 with its highest-ever order backlog, testing its ability to sustain a turnaround in the Industrial Infra segment while navigating seasonal revenue shifts. Investors will focus on the company's progress in recovering Chemicals segment margins and the execution status of key bio-CNG performance trials.
| Results date | July 30, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Previous quarter revenue | Rs. 3,428 Cr |
| Previous quarter PAT | Rs. 244 Cr |
| Market cap | Rs. 53,787.15 Cr |
| CMP | Rs. 4,514.0 |
The board will meet on July 30, 2026 to consider unaudited standalone and consolidated Q1 FY27 results.
Management will discuss Q1 FY27 results on July 31, 2026 at 11:00 AM IST via an investor conference call.
Thermax faces a critical Q1 test as it aims to maintain double-digit revenue growth momentum against a seasonally weaker Q1 FY26 base of Rs. 2,150 Cr. The Industrial Infra segment, which saw PBIT margins expand to 6.5% in Q4 FY26, is expected to show directional stability as the company works through the remaining 38% of legacy low-margin orders. In the Chemicals business, where PBIT margins fell to 4.9% in Q4 FY26, the temporary styrene import duty exemption from April to June 2026 is expected to provide some relief, though a return to the 13-14% margin target remains a medium-term goal. The Green Solutions segment continues to be a narrative-driven story, with management committed to completing bio-CNG performance trials during Q1 and Q2 FY27. Finally, management's ability to navigate geopolitical risks in the Middle East and maintain execution efficiency will be central to the upcoming earnings call.
Performance vs Guidance Tracking
Strategic execution and project updates
Risks and headwinds to monitor
Management attributed the contraction to a combination of factors: 60% of the shortfall was due to depreciation from new assets, 20% from growth investments in Fortmax and international expansion, and 20% from base cost increases.
While management believes bio-CNG could become a Rs. 1,000 Cr revenue opportunity, it currently faces challenges regarding commercial viability and requires policy interventions. Performance trials for existing orders are ongoing, with completion expected in Q1 and Q2 of FY27.
The company has been executing its legacy low-margin orders, with 62% of the identified backlog cleared in H2 FY26. Approximately 38% of this pendency remains to be executed through FY27.
The company is currently at 300 MW capacity and aims to cross 500 MW by the end of FY27. This is part of a broader projection to add approximately 700 MW in FY27 and 1.1 GW by the end of FY28.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now